Emerging Litigation – Zantac (Ranitidine)

Case Review Focus Areas: Whether the patient took Zantac (Ranitidine)?Did the patient develop cancerWhen and where was the injury diagnosed?The extent and duration of the cancer injury from ZantacTreatment/management of the Adverse Events (AE’s) as a result of the exposure to the ZantacFollow-up visits for management of complications/AEsOutcome/prognosisAny medical/surgical history, social history that could have